Sima Halevy

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

Maja Mockenhaupt, Cécile Viboud, Ariane Dunant et al. · Journal of Investigative Dermatology · 2007 · 978 citations · Full text

Drug Safety, Toxic Epidermal Necrolysis, Recently Marketed Drugs +10

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Sylvia H. Kardaun, Alexis Sidoroff, L. Valeyrie‐Allanore et al. · British Journal of Dermatology · 2007 · 907 citations

A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

Christine Lonjou, Nicolas Borot, Peggy Sekula et al. · Pharmacogenetics and Genomics · 2008 · 614 citations

Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR)

Alexis Sidoroff, Ariane Dunant, Cécile Viboud et al. · British Journal of Dermatology · 2007 · 554 citations

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

Sima Halevy, Pierre‐Dominique Ghislain, Maja Mockenhaupt et al. · Journal of the American Academy of Dermatology · 2007 · 473 citations

Toxic Epidermal Necrolysis, Stevens-johnson Syndrome, Pathology +5